Vanguard Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,775,342
Closed -$293M 4596
2021
Q2
$293M Sell
1,775,342
-4,194,199
-70% -$693M 0.01% 1365
2021
Q1
$915M Sell
5,969,541
-739,600
-11% -$113M 0.02% 660
2020
Q4
$842M Buy
6,709,141
+120,184
+2% +$15.1M 0.02% 642
2020
Q3
$668M Sell
6,588,957
-248,523
-4% -$25.2M 0.02% 659
2020
Q2
$665M Sell
6,837,480
-164,873
-2% -$16M 0.02% 636
2020
Q1
$581M Buy
7,002,353
+144,138
+2% +$12M 0.02% 613
2019
Q4
$762M Buy
6,858,215
+25,752
+0.4% +$2.86M 0.03% 641
2019
Q3
$678M Buy
6,832,463
+460,968
+7% +$45.7M 0.03% 655
2019
Q2
$632M Buy
6,371,495
+78,746
+1% +$7.81M 0.02% 691
2019
Q1
$694M Buy
6,292,749
+180,312
+3% +$19.9M 0.03% 631
2018
Q4
$562M Buy
6,112,437
+300,465
+5% +$27.6M 0.03% 657
2018
Q3
$640M Buy
5,811,972
+658,191
+13% +$72.5M 0.03% 675
2018
Q2
$481M Sell
5,153,781
-243,192
-5% -$22.7M 0.02% 802
2018
Q1
$448M Sell
5,396,973
-16,064
-0.3% -$1.33M 0.02% 803
2017
Q4
$493M Buy
5,413,037
+16,292
+0.3% +$1.48M 0.02% 761
2017
Q3
$411M Buy
5,396,745
+839,951
+18% +$64M 0.02% 809
2017
Q2
$342M Sell
4,556,794
-102,798
-2% -$7.71M 0.02% 896
2017
Q1
$304M Buy
4,659,592
+170,812
+4% +$11.1M 0.02% 942
2016
Q4
$247M Buy
4,488,780
+846,093
+23% +$46.6M 0.01% 1037
2016
Q3
$206M Buy
3,642,687
+252,494
+7% +$14.3M 0.01% 1087
2016
Q2
$142M Buy
3,390,193
+852,713
+34% +$35.6M 0.01% 1267
2016
Q1
$109M Buy
2,537,480
+580,891
+30% +$24.8M 0.01% 1429
2015
Q4
$88.6M Buy
1,956,589
+309,841
+19% +$14M 0.01% 1546
2015
Q3
$63.9M Buy
1,646,748
+163,832
+11% +$6.36M ﹤0.01% 1735
2015
Q2
$53.9M Buy
1,482,916
+157,943
+12% +$5.74M ﹤0.01% 1898
2015
Q1
$38.2M Buy
1,324,973
+1,290,196
+3,710% +$37.2M ﹤0.01% 2033
2014
Q4
$842K Buy
+34,777
New +$842K ﹤0.01% 3588